SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Parkin DM,Bray F,Ferlay J,Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74108.
  • 2
    Ziegler RG,Hoover RN,Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993; 85: 18191827.
  • 3
    Porter P. “Westernizing” women's risks? Breast cancer in lower-income countries. N Engl J Med. 2008; 358: 213216.
  • 4
    [No authors listed] A manipulated dichotomy in global health policy [editorial]. Lancet. 2000; 355: 1923.
  • 5
    Agarwal G,Pradeep PV,Aggarwal V,Yip CH,Cheung PS. Spectrum of breast cancer in Asian women. World J Surg. 2007; 31: 10311040.
  • 6
    IARC Working Group on the Evaluation of Cancer-Preventive Strategies.IARC Handbooks of Cancer Prevention. Vol. 7: Breast Cancer Screening. Lyon, France: IARC Press; 2002.
  • 7
    Boyle P. Global summit on mammographic screening. Ann Oncol. 2003; 14: 11591160.
  • 8
    Anderson BO,Braun S,Lim S,Smith RA,Taplin S,Thomas DB. Early detection of breast cancer in countries with limited resources. Breast J. 2003; 9( suppl 2): S51S59.
  • 9
    US Preventitive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med. 2002; 137(5 pt 1): 344346.
  • 10
    Remennick L. “Have no time for potential troubles”: Russian immigrant women and breast cancer screening in Israel. J Immigr Health. 2003; 5: 153163.
  • 11
    Anderson BO,Braun S,Carlson RW, et al. Overview of breast health care guidelines for countries with limited resources. Breast J. 2003; 9( suppl 2): S42S50.
  • 12
    Vargas HI,Anderson BO,Chopra R, et al. Diagnosis of breast cancer in countries with limited resources. Breast J. 2003; 9( suppl 2): S60S66.
  • 13
    Carlson RW,Anderson BO,Chopra R, et al. Treatment of breast cancer in countries with limited resources. Breast J. 2003; 9( suppl 2): S67S74.
  • 14
    Anderson BO,Shyyan R,Eniu A, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J. 2006; 12( suppl 1): S3S15.
  • 15
    Smith RA,Caleffi M,Albert US, et al. Breast cancer in limited-resource countries: early detection and access to care. Breast J. 2006; 12( suppl 1): S16S26.
  • 16
    Shyyan R,Masood S,Badwe RA, et al. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J. 2006; 12( suppl 1): S27S37.
  • 17
    Eniu A,Carlson RW,Aziz Z, et al. Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J. 2006; 12( suppl 1): S38S53.
  • 18
    Anderson BO,Yip CH,Ramsey SD, et al. Breast cancer in limited-resource countries: health care systems and public policy. Breast J. 2006; 12( suppl 1): S54S69.
  • 19
    Anderson BO,Yip CH,Smith RA, et al. Guideline implementation for breast healthcare in low- and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer. 2008; 113( suppl 8): 22212243.
  • 20
    Gopal RL,Beaver K,Barnett T,Ismail NS. A comparison of the information needs of women newly diagnosed with breast cancer in Malaysia and the United Kingdom. Cancer Nurs. 2005; 28: 132140.
  • 21
    Saslow D,Hannan J,Osuch J, et al. Clinical breast examination: practical recommendations for optimizing performance and reporting. CA Cancer J Clin. 2004; 54: 327344.
  • 22
    Barton MB,Harris R,Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA. 1999; 282: 12701280.
  • 23
    Institute of Medicine, Committee for the Study of the Future of Public Health. Mammography and Beyond: Developing Technologies for the Early Detection of Breast Cancer. Bethedsa, MD: Institute of Medicine, 2001.
  • 24
    Tabar L,Fagerberg G,Chen HH, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer. 1995; 75: 25072517.
  • 25
    Kriege M,Brekelmans CT,Obdeijn IM, et al. Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. Breast Cancer Res Treat. 2006; 100: 109119.
  • 26
    Ovretveit J. Evaluating Health Internventions. Philadelphia: Open University Press; 2001.
  • 27
    European Commission, Europe Against Cancer Programme. Evaluation and Monitoring of Screening Programmes. Luxembourg: Office for Official Publications of the European Communities; 2000.
  • 28
    Smith RA,Duffy SW,Gabe R,Tabar L,Yen AM,Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 2004; 42: 793806.
  • 29
    Miles A,Cockburn J,Smith RA,Wardle J. A perspective from countries using organized screening programs. Cancer. 2004; 101( 5 suppl): 12011213.
  • 30
    European Commission. European Guidelines for Quality Assurance in Mammographic Screening. 3rd ed. Luxembourg: Office for Official Publications of the European Communities; 2001.
  • 31
    Monsees BS. The Mammography Quality Standards Act. An overview of the regulations and guidance. Radiol Clin North Am. 2000; 38: 759772.
  • 32
    Klabunde C,Bouchard F,Taplin S,Scharpantgen A,Ballard-Barbash R. Quality assurance for screening mammography: an international comparison. J Epidemiol Commun Health. 2001; 55: 204212.
  • 33
    Klabunde CN,Sancho-Garnier H,Taplin S,Thoresen S,Ohuchi N,Ballard-Barbash R. Quality assurance in follow-up and initial treatment for screening mammography programs in 22 countries. Int J Qual Health Care. 2002; 14: 449461.
  • 34
    Moore MA,Tajima K,Anh PH, et al. Grand challenges in global health and the practical prevention program? Asian focus on cancer prevention in females of the developing world. Asian Pac J Cancer Prev. 2003; 4: 153165.
  • 35
    Humphrey LL,Helfand M,Chan BK,Woolf SH. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002; 137(5 pt 1): 347360.
  • 36
    Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev. 2006; 15: 4551.
  • 37
    Swedish Organised Service Screening Evaluation Group. Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer. 2007; 109: 22052212.
  • 38
    Tabar L,Duffy SW,Vitak B,Chen HH,Prevost TC. The natural history of breast carcinoma: what have we learned from screening? Cancer. 1999; 86: 449462.
  • 39
    Harvey BJ,Miller AB,Baines CJ,Corey PN. Effect of breast self-examination techniques on the risk of death from breast cancer. CMAJ. 1997; 157: 12051212.
  • 40
    Gastrin G,Miller AB,To T, et al. Incidence and mortality from breast cancer in the Mama Program for Breast Screening in Finland, 1973-1986. Cancer. 1994; 73: 21682174.
  • 41
    Thomas DB,Gao DL,Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst. 2002; 94: 14451457.
  • 42
    Weiss NS. Breast cancer mortality in relation to clinical breast examination and breast self-examination. Breast J. 2003; 9( suppl 2): S86S89.
  • 43
    Oestreicher N,Lehman CD,Seger DJ,Buist DS,White E. The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program. AJR Am J Roentgenol. 2005; 184: 428432.
  • 44
    Bancej C,Decker K,Chiarelli A,Harrison M,Turner D,Brisson J. Contribution of clinical breast examination to mammography screening in the early detection of breast cancer. J Med Screen. 2003; 10: 1621.
  • 45
    Bobo J,Lee N. Factors associated with accurate cancer detection during a clinical breast examination. Ann Epidemiol. 2000; 10: 463463.
  • 46
    Boulos S,Gadallah M,Neguib S, et al. Breast screening in the emerging world: high prevalence of breast cancer in Cairo. Breast. 2005; 14: 340346.
  • 47
    Pisani P,Parkin DM,Ngelangel C, et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer. 2006; 118: 149154.
  • 48
    Dinshaw K,Mishra G,Shastri S, et al. Determinants of compliance in a cluster randomised controlled trial on screening of breast and cervix cancer in Mumbai, India. 2. Compliance to referral and treatment. Oncology. 2007; 73: 154161.
  • 49
    Dinshaw K,Mishra G,Shastri S, et al. Determinants of compliance in a cluster randomised controlled trial on screening of breast and cervix cancer in Mumbai, India. 1. Compliance to screening. Oncology. 2007; 73: 145153.
  • 50
    Willey SC,Cocilovo C. Screening and follow-up of the patient at high risk for breast cancer. Obstet Gynecol. 2007; 110: 14041416.
  • 51
    Park BW,Kim SI,Kim MH,Kim EK,Park SH,Lee KS. Clinical breast examination for screening of asymptomatic women: the importance of clinical breast examination for breast cancer detection. Yonsei Med J. 2000; 41: 312318.
  • 52
    Freedman LS,Edwards BK,Ries LAG,Young JL. Cancer Incidence in 4 Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared With US SEER. NIH Pub. No. 06-5873. Bethesda, MD: National Cancer Institute; 2006.
  • 53
    Wong IO,Cowling BJ,Schooling CM,Leung GM. Age-period-cohort projections of breast cancer incidence in a rapidly transitioning Chinese population. Int J Cancer. 2007; 121: 15561563.
  • 54
    Chia KS,Reilly M,Tan CS, et al. Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer. 2005; 113: 302306.
  • 55
    Smith RA. Risk-based screening for breast cancer: is there a practical strategy? Semin Breast Dis. 1999; 2: 280291.
  • 56
    Parsa P,Kandiah M,Abdul Rahman H,Zulkefli NM. Barriers for breast cancer screening among Asian women: a mini literature review. Asian Pac J Cancer Prev. 2006; 7: 509514.
  • 57
    Remennick L. The challenge of early breast cancer detection among immigrant and minority women in multicultural societies. Breast J. 2006; 12( suppl 1): S103S110.
  • 58
    Caffarella RS. Planning Programs for Adult Learners: A Practical Guide for Educators, Trainers, and Staff Developers. 2nd ed. New York: Jossey-Bass; 2002.
  • 59
    Daley BJ. Aligning health promotion and adult education for healthier communities. In: MerriamSB,CourtenayBC,CerveroRM, eds. Global Issues and Adult Education: Perspectives from Latin America, Southern Africa, and the United States. San Francisco: Jossey-Bass; 2006: 231242.
  • 60
    Endresen K,Von Kotze A. Living while being alive: education and learning the treatment action campaign. Int J Lifelong Educ. 2006; 24: 431441.
  • 61
    Giraldo MA. Women facing internal conflict: the challenge for adult education. In: MerriamSB,CourtenayBC,CerveroRM, eds. Global Issues and Adult Education: Perspectives From Latin America, Southern Africa, and the United States. San Francisco: Jossey-Bass; 2006: 118128.
  • 62
    Merriam SB,Mohamad M. How cultural values shape learning in older adulthood: the case of Malaysia. Adult Educ Q. 2000; 51: 4563.
  • 63
    Shroff FM. Ayurveda: mother of indigenous medicine. In: GeorgeS,SefaD,HallBL, eds. Indigenous Knowledge in Global Contexts. Toronto, Ontario, Canada: University of Toronto Press; 2000: 216233.
  • 64
    Kreps GL. Promoting a consumer orientation to health care and health promotion. J Health Psych. 1996; 1: 4148.
  • 65
    Maibach EW,Kreps GL,Bonaguro EW. Developing strategic communication campaigns for HIV/AIDS prevention. In: RatzanS, ed. AIDS: Effective Health Communication for the 90s. Washington, DC: Taylor and Francis; 1993: 1535.
  • 66
    Minkler M. Using participatory action research to build healthy communities. Public Health Rep. 2000; 115: 191197.
  • 67
    Dowse R,Ehlers M. Medicine labels incorporating pictograms: do they influence understanding and adherence? Patient Educ Couns. 2005; 58: 6370.
  • 68
    Gustafsson J,Kalvemark S,Nilsson G,Nilsson JL. Patient information leaflets—patients' comprehension of information about interactions and contraindications. Pharm World Sci. 2005; 27: 3540.
  • 69
    Hwang SW,Tram CQ,Knarr N. The effect of illustrations on patient comprehension of medication instruction labels. BMC Fam Pract. 2005; 6: 26.
  • 70
    Knapp P,Raynor DK,Jebar AH,Price SJ. Interpretation of medication pictograms by adults in the UK. Ann Pharmacother. 2005; 39: 12271233.
  • 71
    Taib NA,Yip CH,Ibrahim M,Ng CJ,Farizah H. Breast cancer in Malaysia: are our women getting the right message? 10 year-experience in a single institution in Malaysia. Asian Pac J Cancer Prev. 2007; 8: 141145.
  • 72
    Kreps GL. Evaluating new health information technologies: expanding the frontiers of health care delivery and health promotion. Stud Health Technol Inform. 2002; 80: 205212.
  • 73
    Semiglazov VF,Sagaidak VN,Moiseyenko VM,Mikhailov EA. Study of the role of breast self-examination in the reduction of mortality from breast cancer. The Russian Federation/World Health Organization Study. Eur J Cancer. 1993; 29A: 20392046.
  • 74
    Groot MT,Baltussen R,Uyl-de Groot CA,Anderson BO,Hortobagyi GN. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. Breast J. 2006; 12( suppl 1): S81S90.